In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Viz.ai closes $50mm Series B round to expand computer-aided stroke triage software

Executive Summary

Viz.ai Inc. (artificial intelligence (AI) algorithms to detect and triage stroke) closed a $50mm Series B round led by Greenoaks, which was joined by other new backers Threshold Ventures and CRV, along with returning investors GV and Kleiner Perkins. The company's FDA-cleared, cloud-based AI-powered software cross-references CT scans of a patient’s brain with database images to identify suspected large-vessel occlusions and alert a stroke specialist within minutes, providing the patient with a shorter time to treatment and synchronized care. Viz.ai will use the proceeds to expand its software to more disease states and geographies. Including the current round, the 2016 start-up has raised $78.5mm to date.

Deal Industry
  • Medical Devices
  • Medical Devices
    • Diagnostic Equipment & Supplies
    • Diagnostic Imaging Equipment & Supplies
  • Digital Health
    • Artificial Intelligence
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register